Owens & Minor - OMI STOCK NEWS

Owens & Minor (NYSE:OMI) has announced the pricing of its $1 billion senior secured notes offering due 2030, bearing a 10.000% interest rate. The notes, priced at 100% of principal amount, are expected to close on April 4, 2025.

The proceeds will primarily finance the previously announced acquisition of Rotech Healthcare Holdings. Until the acquisition closes, the proceeds will be held in escrow. The notes will be guaranteed by OMI and certain domestic subsidiaries, secured by first-priority liens on assets securing the company's existing loan facilities.

The funding package includes the notes offering proceeds, cash on hand, and planned borrowings under a new senior secured incremental term loan B facility. These funds will cover the acquisition costs, Rotech debt repayment, and related expenses.

Owens & Minor (NYSE:OMI) has announced a private offering of $600 million senior secured notes due 2030. The proceeds will be used to finance the previously announced acquisition of Rotech Healthcare Holdings, along with cash on hand and borrowings from a new senior secured incremental term loan B facility.

The notes will be guaranteed by certain domestic subsidiaries and secured by first-priority liens on company assets. Initially, if issued before the Rotech acquisition closes, the notes will only be secured by the escrow account holding the proceeds. The offering is to qualified institutional buyers under Rule 144A and non-U.S. persons under Regulation S.

The funds will cover the acquisition costs, repayment of Rotech debt, related fees and expenses, with remaining proceeds for working capital. The offering is not contingent on completing the Rotech acquisition, which may occur after the offering closes.

Owens & Minor (NYSE: OMI) has announced significant financial developments and strategic initiatives. The company has achieved a total debt reduction of $647 million over two years, with $244 million reduced in 2024. The company is actively pursuing the sale of its Products & Healthcare Services (P&HS) segment and has authorized a $100 million share repurchase program over 24 months.

For 2025, OMI projects revenue between $10.85-11.15 billion, adjusted EBITDA of $560-590 million, and adjusted EPS of $1.60-1.85. The guidance indicates double-digit adjusted EBITDA and EPS growth with improving cash flow. The outlook excludes impacts from the announced Rotech acquisition, potential P&HS segment sale, and share repurchase activity.

Owens & Minor (NYSE: OMI) has launched ByramConnect, a digital health platform powered by the Welldoc App, exclusively for Byram Healthcare customers. The FDA-cleared class II software medical device is designed to help patients with type 1 or type 2 diabetes and associated chronic conditions.

The platform combines AI-driven digital health coaching, self-tracking, and clinical insights across six health dimensions. It integrates with various devices including blood glucose meters, CGMs, blood pressure monitors, and fitness trackers. Clinical studies have shown improvements in key metrics including reduced A1C, lower blood pressure, and reduced body weight.

Key features include personalized digital coaching, diet and nutrition support, GLP-1 medication management, health reporting with actionable insights, and mental wellbeing guidance. The service is available at no additional charge to Byram diabetes customers.

Owens & Minor (NYSE: OMI) has announced preliminary financial results for Q4 and full-year 2024, coinciding with financing activities for its planned Rotech Healthcare acquisition. The company expects to report Q4 2024 revenue of $2.67-$2.70 billion and full-year revenue of $10.67-$10.70 billion.

Key highlights include a non-cash goodwill impairment charge of approximately $310 million in the Apria division, resulting in a net loss of $(311)-(288) million for Q4 and $(378)-(355) million for the full year. The Patient Direct segment showed mid-single digit growth, and the company reduced total debt by over $240 million in 2024.

The company's Q4 Adjusted EBITDA is expected at $135-$140 million, with full-year Adjusted EBITDA of $520-$525 million. Full-year total debt stands at $1.854-$1.859 billion. The company plans to release complete financial results on February 28, 2025.

Owens & Minor (NYSE: OMI) has announced its participation in two upcoming investor conferences in December 2024. The company will participate in a fireside chat at the Citi 2024 Global Healthcare Conference in Miami, Florida on December 4 at 8:45 a.m. ET, and at the Bank of America Home Care Conference virtually on December 9 at 12:00 p.m. ET. Both events will include individual investor meetings.

Owens & Minor is a Fortune 500 global healthcare solutions company that provides essential products and services from hospital to home care. With over 20,000 teammates worldwide, the company operates through affiliated brands including Apria, Byram, and HALYARD.

Owens & Minor (NYSE: OMI) reported Q3 2024 financial results with consolidated revenue of $2.7 billion, up 5% year-over-year. The company posted a GAAP net loss of $(13) million or $(0.17) per share, with adjusted earnings per share of $0.42. Patient Direct revenue grew 6% to $687 million, while Products & Healthcare Services revenue increased 5% to $2.0 billion. The company achieved $198 million in total debt reduction and reported adjusted EBITDA of $142 million, up 5% year-over-year. For 2024, guidance includes revenue of $10.6-10.8 billion, adjusted EBITDA of $540-550 million, and adjusted EPS of $1.45-1.55.

Owens & Minor (NYSE: OMI) has announced its plans to release financial results for the third quarter of 2024 on Monday, November 4, 2024, before trading begins on the New York Stock Exchange. The company will host a conference call for investors and analysts at 8:30 a.m. ET on the same day.

Participants can access the call via toll-free dial-in at 1-888-300-2035 or toll dial-in at 1-646-517-7437, using the conference ID access code 1058917. A simultaneous live webcast will be available on the Investor Relations page of the Owens & Minor website. A replay of the webcast can be accessed following the presentation.

Owens & Minor is a Fortune 500 global healthcare solutions company providing essential products and services that support care from hospital to home. With over 100 years of experience, the company and its affiliated brands serve patients, providers, and communities worldwide.

Owens & Minor (NYSE: OMI) has appointed Jonathan Leon as Executive Vice President and Chief Financial Officer, effective immediately. Leon, who has been with the company since 2017, will retain his corporate treasurer responsibilities while a search for his successor is underway. He brings over 25 years of experience in corporate finance, treasury, and strategy to the role.

Leon previously served as Interim CFO and Corporate Treasurer since June 2024. He will report directly to Edward Pesicka, President and CEO of Owens & Minor. Before joining the company, Leon spent 18 years at The Brink's Company in various finance roles. The appointment follows a comprehensive process, with the Board unanimously agreeing on Leon's suitability for the position.